Back to Search Start Over

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series.

Authors :
Murakami Y
Shinohara M
Oka Y
Wada R
Noike R
Ohara H
Fujino T
Ikeda T
Source :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Feb 15; Vol. 61 (4), pp. 501-505. Date of Electronic Publication: 2021 Nov 27.
Publication Year :
2022

Abstract

COVID-19 vaccine-related myocarditis has been reported worldwide. We herein report two Japanese cases with suspected vaccine-related myocarditis. A 27-year-old man was admitted with chest pain 4 days after the second vaccination. An electrocardiogram (ECG) did not reveal any significant abnormalities. The second patient, a 37-year-old man, was admitted with chest pain 9 days after the first vaccination. His ECG exhibited ST-elevation in multiple leads. In both cases, cardiac magnetic resonance imaging findings were consistent with myocarditis. They recovered with symptomatic relief within a few days. These cases suggest that the benefit of COVID-19 vaccination exceeds the risk of vaccine-related myocarditis.

Details

Language :
English
ISSN :
1349-7235
Volume :
61
Issue :
4
Database :
MEDLINE
Journal :
Internal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
34840235
Full Text :
https://doi.org/10.2169/internalmedicine.8731-21